Handcrafted Brilliant Violet 421™ Anti-human Cd7 - Limited Release [9RoCSH8s]

Brilliant Violet 421™ Anti-Human CD7

The Handcrafted Brilliant Violet 421™ Anti-human Cd7 - Limited Release [9RoCSH8s], clone A20153E, is a highly specialized monoclonal antibody designed for the detection and analysis of CD7, a crucial marker expressed on various immune cells. This product offers a unique format, BV421, which provides excellent fluorescence properties for flow cytometry applications. With its specific reactivity to human CD7, this antibody is an essential tool for researchers studying hematopoietic cells, T cells, NK cells, and acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) cells.

Product Specifications and Features

The Handcrafted Brilliant Violet 421™ Anti-human Cd7 - Limited Release [9RoCSH8s] is a mouse monoclonal antibody with an IgG2b, κ isotype. It is formatted in BV421, a vibrant fluorescent dye that enhances signal detection and reduces background noise. This antibody has been quality tested for flow cytometry (FC) applications, ensuring reliable results. The host species is mouse, and it is suitable for use in various experimental settings. Key features include:

Monoclonal antibody specificity for human CD7

BV421 conjugation for enhanced fluorescence

Quality tested for flow cytometry applications

Applications and Benefits

The Handcrafted Brilliant Violet 421™ Anti-human Cd7 - Limited Release [9RoCSH8s] is a versatile tool for researchers in immunology, hematology, and oncology. Its ability to detect CD7 expression on T cells, NK cells, and leukemic cells makes it particularly valuable for diagnostic and research purposes. The following scenarios highlight the practical uses and benefits of this product:

Diagnosis and monitoring of ALL and AML

Analysis of hematopoietic cell subsets

Investigation of T cell function and signaling

By utilizing this antibody, researchers can gain deeper insights into the role of CD7 in immune cell function and disease progression, ultimately leading to improved diagnostic methods and therapeutic strategies.